{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T14:44:16Z","timestamp":1793371456292,"version":"4.5.0"},"reference-count":130,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.jns.2022.120302","type":"journal-article","created":{"date-parts":[[2022,5,30]],"date-time":"2022-05-30T20:13:21Z","timestamp":1653941601000},"page":"120302","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"special_numbering":"C","title":["Review of otential sychedelic reatments for PTSD"],"prefix":"10.1016","volume":"439","author":[{"given":"Ryan L.","family":"Henner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matcheri S.","family":"Keshavan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin P.","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2022.120302_bb0005","series-title":"Diagnostic and Statistical Manual of Mental Disorders: DSM-5","year":"2013"},{"key":"10.1016\/j.jns.2022.120302_bb0010","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1017\/S0033291717000708","article-title":"Posttraumatic stress disorder in the world mental health surveys","volume":"47","author":"Koenen","year":"2017","journal-title":"Psychol. Med."},{"key":"10.1016\/j.jns.2022.120302_bb0015","series-title":"Guideline Development Panel for the Treatment of PTSD in Adults. Clinical Practice Guideline for the Treatment of Posttraumatic Stress Disorder (PTSD) in Adults. Washington DC","author":"American Psychological Association","year":"2017"},{"key":"10.1016\/j.jns.2022.120302_bb0020","doi-asserted-by":"crossref","first-page":"1853379","DOI":"10.1080\/20008198.2020.1853379","article-title":"Pharmacological-assisted psychotherapy for post-traumatic stress disorder: a systematic review and meta-analysis","volume":"12","author":"Hoskins","year":"2021","journal-title":"Eur. J. Psychotraumatol."},{"key":"10.1016\/j.jns.2022.120302_bb0025","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1017\/S003329171700349X","article-title":"Comparative efficacy and acceptability of pharmacological treatments for post-traumatic stress disorder in adults: A network meta-analysis","volume":"48","author":"Cipriani","year":"2017","journal-title":"Psychol. Med."},{"key":"10.1016\/j.jns.2022.120302_bb0030","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1037\/pst0000231","article-title":"A guide to guidelines for the treatment of posttraumatic stress disorder in adults: an update","volume":"56","author":"Hamblen","year":"2019","journal-title":"Psychotherapy"},{"key":"10.1016\/j.jns.2022.120302_bb0035","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1177\/2167702615598756","article-title":"The lingering impact of resolved PTSD on subsequent functioning","volume":"4","author":"Bryant","year":"2015","journal-title":"Clin. Psychol. Sci."},{"key":"10.1016\/j.jns.2022.120302_bb0040","doi-asserted-by":"crossref","first-page":"26","DOI":"10.35502\/jcswb.6","article-title":"On the economics of post-traumatic stress disorder among first responders in Canada","volume":"1","author":"Wilson","year":"2016","journal-title":"J. Commun. Safety Well-Being"},{"key":"10.1016\/j.jns.2022.120302_bb0045","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0022-3956(01)00032-2","article-title":"Relationship of parental trauma exposure and PTSD to PTSD, depressive and anxiety disorders in offspring","volume":"35","author":"Yehuda","year":"2001","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jns.2022.120302_bb0050","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1097\/00004583-199509000-00013","article-title":"Posttraumatic stress disorder across two generations of Cambodian refugees","volume":"34","author":"Sack","year":"1995","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.jns.2022.120302_bb0055","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1136\/jnnp-2016-314998","article-title":"Cingulo-insular structural alterations associated with psychogenic symptoms, childhood abuse and PTSD in functional neurological disorders","volume":"88","author":"Perez","year":"2017","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jns.2022.120302_bb0060","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.biopsych.2010.07.018","article-title":"The neural correlates of emotional memory in posttraumatic stress disorder","volume":"68","author":"Brohawn","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jns.2022.120302_bb0065","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/hbm.20415","article-title":"Enhanced amygdala and medial prefrontal activation during nonconscious processing of fear in posttraumatic stress disorder: an fmri study","volume":"29","author":"Bryant","year":"2007","journal-title":"Hum. Brain Mapp."},{"key":"10.1016\/j.jns.2022.120302_bb0070","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1017\/S0033291704003290","article-title":"Positron emission tomographic imaging of neural correlates of a fear acquisition and extinction paradigm in women with childhood sexual-abuse-related post-traumatic stress disorder","volume":"35","author":"Bremner","year":"2004","journal-title":"Psychol. Med."},{"key":"10.1016\/j.jns.2022.120302_bb0075","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1017\/S003329171700263X","article-title":"Diminished medial prefrontal cortex activation during the recollection of stressful events is an acquired characteristic of PTSD","volume":"48","author":"Dahlgren","year":"2017","journal-title":"Psychol. Med."},{"key":"10.1016\/j.jns.2022.120302_bb0080","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/s00406-005-0617-3","article-title":"Disturbance in the neural circuitry underlying positive emotional processing in post\u2013traumatic stress disorder (PTSD)","volume":"256","author":"Jatzko","year":"2005","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.jns.2022.120302_bb0085","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/hipo.10183","article-title":"Hippocampal function in posttraumatic stress disorder","volume":"14","author":"Shin","year":"2004","journal-title":"Hippocampus"},{"key":"10.1016\/j.jns.2022.120302_bb0090","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.neuroimage.2005.02.032","article-title":"Parahippocampal activation evoked by masked traumatic images in posttraumatic stress disorder: A functional MRI study","volume":"26","author":"Sakamoto","year":"2005","journal-title":"NeuroImage"},{"key":"10.1016\/j.jns.2022.120302_bb0095","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.jpsychires.2010.10.011","article-title":"Functional neuroimaging of emotionally intense autobiographical memories in post-traumatic stress disorder","volume":"45","author":"St Jacques","year":"2011","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jns.2022.120302_bb0100","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1503\/jpn.110069","article-title":"Altered resting-state amygdala functional connectivity in men with posttraumatic stress disorder","volume":"37","author":"Sripada","year":"2012","journal-title":"J. Psychiatry Neurosci."},{"key":"10.1016\/j.jns.2022.120302_bb0105","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1097\/HRP.0000000000000185","article-title":"Functional neuroanatomy of emotion and its regulation in PTSD","volume":"26","author":"Fitzgerald","year":"2018","journal-title":"Harvard Rev. Psychiatry"},{"key":"10.1016\/j.jns.2022.120302_bb0110","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/S0006-3223(99)00044-X","article-title":"Developmental traumatology part I: biological stress systems","volume":"45","author":"De Bellis","year":"1999","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jns.2022.120302_bb0115","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.biopsych.2019.07.009","article-title":"Translating molecular and neuroendocrine findings in posttraumatic stress disorder and resilience to novel therapies","volume":"86","author":"DePierro","year":"2019","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jns.2022.120302_bb0120","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0005-7967(66)90083-0","article-title":"Modification of expectations in cases with obsessional rituals","volume":"4","author":"Meyer","year":"1966","journal-title":"Behav. Res. Ther."},{"key":"10.1016\/j.jns.2022.120302_bb0125","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1017\/S0033291706007963","article-title":"Comparing the efficacy of EMDR and trauma-focused cognitive-behavioral therapy in the treatment of PTSD: a meta-analytic study","volume":"36","author":"Seidler","year":"2006","journal-title":"Psychol. Med."},{"key":"10.1016\/j.jns.2022.120302_bb0130","doi-asserted-by":"crossref","first-page":"1568132","DOI":"10.1080\/20008198.2019.1568132","article-title":"Fear extinction learning improvement in PTSD after EMDR therapy: an fMRI study","volume":"10","author":"Rousseau","year":"2019","journal-title":"Eur. J. Psychotraumatol."},{"key":"10.1016\/j.jns.2022.120302_bb0135","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.cpr.2015.06.008","article-title":"The efficacy of recommended treatments for veterans with PTSD: A metaregression analysis","volume":"40","author":"Haagen","year":"2015","journal-title":"Clin. Psychol. Rev."},{"key":"10.1016\/j.jns.2022.120302_bb0140","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1001\/jama.2019.20825","article-title":"First-line psychotherapies for military-related PTSD","volume":"323","author":"Steenkamp","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.jns.2022.120302_bb0145","doi-asserted-by":"crossref","DOI":"10.3389\/fnbeh.2018.00258","article-title":"Treating PTSD: A review of evidence-based psychotherapy interventions","volume":"12","author":"Watkins","year":"2018","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.jns.2022.120302_bb0150","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.brat.2019.03.003","article-title":"Predictors of attendance and dropout in three randomized controlled trials of PTSD treatment for active duty service members","volume":"118","author":"Berke","year":"2019","journal-title":"Behav. Res. Ther."},{"key":"10.1016\/j.jns.2022.120302_bb0155","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1002\/jts.22038","article-title":"A systematic review of dropout from psychotherapy for posttraumatic stress disorder among Iraq and Afghanistan combat veterans","volume":"28","author":"Goetter","year":"2015","journal-title":"J. Trauma. Stress."},{"key":"10.1016\/j.jns.2022.120302_bb0160","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1080\/02791072.1986.10472362","article-title":"Differences between the mechanism of action of MDMA, MBDB, and the classic hallucinogens. Identification of a new therapeutic class: Entactogens","volume":"18","author":"Nichols","year":"1986","journal-title":"J. Psychoactive Drugs"},{"key":"10.1016\/j.jns.2022.120302_bb0165","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2017.00455","article-title":"MDMA-induced dissociative state not mediated by the 5-HT2A receptor","volume":"8","author":"Puxty","year":"2017","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jns.2022.120302_bb0170","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.cub.2016.12.030","article-title":"The fabric of meaning and subjective effects in LSD-induced states depend on serotonin 2A receptor activation","volume":"27","author":"Preller","year":"2017","journal-title":"Curr. Biol."},{"key":"10.1016\/j.jns.2022.120302_bb0175","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s40501-019-00172-0","article-title":"Augmenting the treatment of PTSD with ketamine\u2014a review","volume":"6","author":"Duek","year":"2019","journal-title":"Curr. Treatment Options Psychiatry"},{"key":"10.1016\/j.jns.2022.120302_bb0180","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/ijnp\/pyaa018","article-title":"Reviewing the potential of psychedelics for the treatment of PTSD","volume":"23","author":"Krediet","year":"2020","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.jns.2022.120302_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107551","article-title":"Cannabinoids as therapeutics for PTSD","volume":"211","author":"Sbarski","year":"2020","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.jns.2022.120302_bb0190","doi-asserted-by":"crossref","first-page":"214","DOI":"10.3390\/life11030214","article-title":"Endocannabinoid system as therapeutic target of PTSD: A systematic review","volume":"11","author":"Steardo","year":"2021","journal-title":"Life"},{"key":"10.1016\/j.jns.2022.120302_bb0195","article-title":"Use of cannabinoids for the treatment of patients with post-traumatic stress disorder","author":"Forsythe","year":"2021","journal-title":"J. Basic Clin. Physiol. Pharmacol."},{"key":"10.1016\/j.jns.2022.120302_bb0200","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2017.00974","article-title":"Quality of acute psychedelic experience predicts therapeutic efficacy of psilocybin for treatment-resistant depression","volume":"8","author":"Roseman","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jns.2022.120302_bb0205","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S2215-0366(16)30065-7","article-title":"Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study","volume":"3","author":"Carhart-Harris","year":"2016","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.jns.2022.120302_bb0210","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1056\/NEJMoa2032994","article-title":"Trial of psilocybin versus escitalopram for depression","volume":"384","author":"Carhart-Harris","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jns.2022.120302_bb0215","series-title":"Bethesda (MD): National Library of Medicine (US). 2000 Feb 29 - . Identifier NCT03775200, The Safety and Efficacy of Psilocybin in Participants With Treatment Resistant Depression (P-TRD)","author":"ClinicalTrials.gov [Internet]","year":"2018"},{"key":"10.1016\/j.jns.2022.120302_bb0220","series-title":"Bethesda (MD): National Library of Medicine (US). 2000 Feb 29 - . Identifier NCT03866174, A Study of Psilocybin for Major Depressive Disorder (MDD)","author":"ClinicalTrials.gov [Internet]","year":"2019"},{"key":"10.1016\/j.jns.2022.120302_bb0225","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1111\/j.1360-0443.2006.01511.x","article-title":"The origin of MDMA (ecstasy) revisited: the true story reconstructed from the original documents","volume":"101","author":"Freudenmann","year":"2006","journal-title":"Addiction"},{"key":"10.1016\/j.jns.2022.120302_bb0230","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1080\/02791072.2015.1128580","article-title":"The history of MDMA as an underground drug in the United States, 1960\u20131979","volume":"48","author":"Passie","year":"2016","journal-title":"J. Psychoactive Drugs"},{"key":"10.1016\/j.jns.2022.120302_bb0235","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1080\/02791072.1986.10472364","article-title":"Subjective reports of the effects of MDMA in a clinical setting","volume":"18","author":"Greer","year":"1986","journal-title":"J. Psychoactive Drugs"},{"key":"10.1016\/j.jns.2022.120302_bb0240","author":"Mithoefer"},{"key":"10.1016\/j.jns.2022.120302_bb0245","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/S2215-0366(18)30135-4","article-title":"3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in military veterans, firefighters, and police officers: a randomised, double-blind, dose-response, phase 2 clinical trial","volume":"5","author":"Mithoefer","year":"2018","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.jns.2022.120302_bb0250","doi-asserted-by":"crossref","DOI":"10.1038\/s41591-021-01336-3","article-title":"MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study","author":"Mitchell","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.jns.2022.120302_bb0255","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.neuroscience.2007.02.032","article-title":"A role for oxytocin and 5-HT1A receptors in the prosocial effects of 3,4 methylenedioxymethamphetamine (\u201cecstasy\u201d)","volume":"146","author":"Thompson","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.jns.2022.120302_bb0260","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1080\/17470910802649470","article-title":"Increased oxytocin concentrations and prosocial feelings in humans after ecstasy (3,4-methylenedioxymethamphetamine) administration","volume":"4","author":"Dumont","year":"2009","journal-title":"Soc. Neurosci."},{"key":"10.1016\/j.jns.2022.120302_bb0265","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.yhbeh.2011.10.012","article-title":"The neuropharmacology of prolactin secretion elicited by 3,4-methylenedioxymethamphetamine (\u201cecstasy\u201d): A concurrent microdialysis and plasma analysis study","volume":"61","author":"Murnane","year":"2012","journal-title":"Horm. Behav."},{"key":"10.1016\/j.jns.2022.120302_bb0270","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/s00213-004-1789-7","article-title":"Repeated doses administration of MDMA in humans: pharmacological effects and pharmacokinetics","volume":"173","author":"Farr\u00e9","year":"2004","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jns.2022.120302_bb0275","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1002\/hup.348","article-title":"Which neuroreceptors mediate the subjective effects of MDMA in humans? A summary of mechanistic studies","volume":"16","author":"Liechti","year":"2001","journal-title":"Hum. Psychopharmacol. Clin. Exp."},{"key":"10.1016\/j.jns.2022.120302_bb0280","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0040187","article-title":"Effects of acute MDMA intoxication on mood and impulsivity: role of the 5-HT2 and 5-HT1 receptors","volume":"7","author":"van Wel","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jns.2022.120302_bb0285","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/clpt.2011.78","article-title":"The norepinephrine transporter inhibitor reboxetine reduces stimulant effects of MDMA (\u201cecstasy\u201d) in humans","volume":"90","author":"Hysek","year":"2011","journal-title":"Clin. Pharmacol. Therapeutics"},{"key":"10.1016\/j.jns.2022.120302_bb0290","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s00213-020-05710-w","article-title":"Discontinuation of medications classified as reuptake inhibitors affects treatment response of MDMA-assisted psychotherapy","volume":"238","author":"Feduccia","year":"2020","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jns.2022.120302_bb0295","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1017\/S1461145713001405","article-title":"The effect of acutely administered MDMA on subjective and BOLD-fMRI responses to favourite and worst autobiographical memories","volume":"17","author":"Carhart-Harris","year":"2013","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.jns.2022.120302_bb0300","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s00213-009-1635-z","article-title":"Effects of MDMA on sociability and neural response to social threat and social reward","volume":"207","author":"Bedi","year":"2009","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jns.2022.120302_bb0305","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1038\/npp.2014.12","article-title":"Effects of MDMA and intranasal oxytocin on social and emotional processing","volume":"39","author":"Kirkpatrick","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jns.2022.120302_bb0310","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.biopsych.2013.12.015","article-title":"The effects of acutely administered 3,4-methylenedioxymethamphetamine on spontaneous brain function in healthy volunteers measured with arterial spin labeling and blood oxygen level\u2013dependent resting state functional connectivity","volume":"78","author":"Carhart-Harris","year":"2015","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jns.2022.120302_bb0315","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1038\/npp.2017.35","article-title":"Altered insula connectivity under MDMA","volume":"42","author":"Walpola","year":"2017","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jns.2022.120302_bb0320","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.pnpbp.2018.03.003","article-title":"MDMA-assisted psychotherapy for PTSD: are memory reconsolidation and fear extinction underlying mechanisms?","volume":"84","author":"Feduccia","year":"2018","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.jns.2022.120302_bb0325","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1124\/pr.115.011478","article-title":"Psychedelics","volume":"68","author":"Nichols","year":"2016","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.jns.2022.120302_bb0330","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1080\/02791072.2019.1580805","article-title":"Perceived benefits of MDMA-assisted psychotherapy beyond symptom reduction: qualitative follow-up study of a clinical trial for individuals with treatment-resistant PTSD","volume":"51","author":"Barone","year":"2019","journal-title":"J. Psychoactive Drugs"},{"key":"10.1016\/j.jns.2022.120302_bb0335","article-title":"A comparison of MDMA-assisted psychotherapy to non-assisted psychotherapy in treatment-resistant PTSD: A systematic review and meta-analysis","volume":"026988112096591","author":"Illingworth","year":"2020","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.jns.2022.120302_bb0340","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1007\/s00213-019-05249-5","article-title":"MDMA-assisted psychotherapy for treatment of PTSD: study design and rationale for phase 3 trials based on pooled analysis of six phase 2 randomized controlled trials","volume":"236","author":"Mithoefer","year":"2019","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jns.2022.120302_bb0345","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1177\/0269881112464827","article-title":"A randomized, controlled pilot study of MDMA (\u00b13,4-Methylenedioxymethamphetamine)-assisted psychotherapy for treatment of resistant, chronic post-traumatic stress disorder (PTSD)","volume":"27","author":"Oehen","year":"2012","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.jns.2022.120302_bb0350","author":"Mathis"},{"key":"10.1016\/j.jns.2022.120302_bb0355","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/npp.2012.178","article-title":"Brain serotonin function in MDMA (ecstasy) users: evidence for persisting neurotoxicity","volume":"38","author":"Benningfield","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jns.2022.120302_bb0360","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1038\/npp.2011.332","article-title":"Sustained recreational use of ecstasy is associated with altered pre and postsynaptic markers of serotonin transmission in neocortical areas: A PET study with [11C]DASB and [11C]MDL 100907","volume":"37","author":"Urban","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jns.2022.120302_bb0365","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00213-012-2936-1","article-title":"Human ecstasy (MDMA) polydrug users have altered brain activation during semantic processing","volume":"227","author":"Watkins","year":"2012","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jns.2022.120302_bb0370","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1177\/0269881105056670","article-title":"Transient memory impairment after acute dose of 75mg 3.4-methylene-dioxymethamphetamine","volume":"19","author":"Kuypers","year":"2005","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.jns.2022.120302_bb0375","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.euroneuro.2017.08.425","article-title":"Discrete memory impairments in largely pure chronic users of MDMA","volume":"27","author":"Wunderli","year":"2017","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.jns.2022.120302_bb0380","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s00213-006-0321-7","article-title":"Acute dose of MDMA (75 mg) impairs spatial memory for location but leaves contextual processing of visuospatial information unaffected","volume":"189","author":"Kuypers","year":"2006","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jns.2022.120302_bb0385","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1124\/pr.118.017087","article-title":"Cognitive effects of MDMA in laboratory animals: A systematic review focusing on dose","volume":"71","author":"Pantoni","year":"2019","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.jns.2022.120302_bb0390","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1007\/s00213-020-05548-2","article-title":"Long-term follow-up outcomes of MDMA-assisted psychotherapy for treatment of PTSD: a longitudinal pooled analysis of six phase 2 trials","volume":"237","author":"Jerome","year":"2020","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jns.2022.120302_bb0395","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1177\/0269881112456611","article-title":"Durability of improvement in post-traumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3,4-methylenedioxymethamphetamine-assisted psychotherapy: a prospective long-term follow-up study","volume":"27","author":"Mithoefer","year":"2012","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.jns.2022.120302_bb0400","series-title":"The Long Trip: A Prehistory of Psychedelia","author":"Devereux","year":"2008"},{"key":"10.1016\/j.jns.2022.120302_bb0405","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1017\/S0033291718001356","article-title":"Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial","volume":"49","author":"Palhano-Fontes","year":"2018","journal-title":"Psychol. Med."},{"key":"10.1016\/j.jns.2022.120302_bb0410","series-title":"LSD: My Problem Child","author":"Hofmann","year":"2018"},{"key":"10.1016\/j.jns.2022.120302_bb0415","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2020.116715","article-title":"A review of emerging therapeutic potential of psychedelic drugs in the treatment of psychiatric illnesses","volume":"411","author":"Chi","year":"2020","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jns.2022.120302_bb0420","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1177\/0269881114565144","article-title":"Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study","volume":"29","author":"Bogenschutz","year":"2015","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.jns.2022.120302_bb0425","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2174\/1874473708666150107121331","article-title":"Psilocybin-occasioned mystical experiences in the treatment of tobacco addiction","volume":"7","author":"Garcia-Romeu","year":"2015","journal-title":"Curr. Drug Abuse Rev."},{"key":"10.1016\/j.jns.2022.120302_bb0430","doi-asserted-by":"crossref","first-page":"141","DOI":"10.31887\/DCNS.2015.17.2\/jflory","article-title":"Comorbidity between post-traumatic stress disorder and major depressive disorder: alternative explanations and treatment considerations","volume":"17","author":"Flory","year":"2015","journal-title":"Dialogues Clin. Neurosci."},{"key":"10.1016\/j.jns.2022.120302_bb0435","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1001\/archpsyc.1995.03950240066012","article-title":"Posttraumatic stress disorder in the National Comorbidity Survey","volume":"52","author":"Kessler","year":"1995","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jns.2022.120302_bb0440","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1521-0391.2011.00126.x","article-title":"Substance use comorbidity among veterans with posttraumatic stress disorder and other psychiatric illness","volume":"20","author":"Petrakis","year":"2011","journal-title":"Am. J. Addict."},{"key":"10.1016\/j.jns.2022.120302_bb0445","doi-asserted-by":"crossref","DOI":"10.3389\/fncom.2015.00076","article-title":"A network model of basal ganglia for understanding the roles of dopamine and serotonin in reward-punishment-risk based decision making","volume":"9","author":"Balasubramani","year":"2015","journal-title":"Front. Comput. Neurosci."},{"key":"10.1016\/j.jns.2022.120302_bb0450","doi-asserted-by":"crossref","DOI":"10.3389\/fnhum.2017.00484","article-title":"An update on the role of serotonin and its interplay with dopamine for reward","volume":"11","author":"Fischer","year":"2017","journal-title":"Front. Hum. Neurosci."},{"key":"10.1016\/j.jns.2022.120302_bb0455","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1038\/s41386-020-0718-8","article-title":"Me, myself, bye: regional alterations in glutamate and the experience of ego dissolution with psilocybin","volume":"45","author":"Mason","year":"2020","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jns.2022.120302_bb0460","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.neubiorev.2008.09.002","article-title":"Default-mode brain dysfunction in mental disorders: A systematic review","volume":"33","author":"Broyd","year":"2009","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.jns.2022.120302_bb0465","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1146\/annurev-neuro-071013-014030","article-title":"The brain\u2019s default mode network","volume":"38","author":"Raichle","year":"2015","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.jns.2022.120302_bb0470","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1600-0447.2009.01391.x","article-title":"Default mode network connectivity as a predictor of post-traumatic stress disorder symptom severity in acutely traumatized subjects","volume":"121","author":"Lanius","year":"2009","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.jns.2022.120302_bb0475","doi-asserted-by":"crossref","DOI":"10.1007\/s11920-017-0840-4","article-title":"A network-based neurobiological model of PTSD: evidence from structural and functional neuroimaging studies","volume":"19","author":"Akiki","year":"2017","journal-title":"Curr. Psychiatry Reports"},{"key":"10.1016\/j.jns.2022.120302_bb0480","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1124\/pr.118.017160","article-title":"Rebus and the anarchic brain: toward a unified model of the brain action of psychedelics","volume":"71","author":"Carhart-Harris","year":"2019","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.jns.2022.120302_bb0485","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-13282-7","article-title":"Psilocybin for treatment-resistant depression: Fmri-measured brain mechanisms","volume":"7","author":"Carhart-Harris","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jns.2022.120302_bb0490","doi-asserted-by":"crossref","first-page":"4853","DOI":"10.1073\/pnas.1518377113","article-title":"Neural correlates of the LSD experience revealed by multimodal neuroimaging","volume":"113","author":"Carhart-Harris","year":"2016","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jns.2022.120302_bb0495","doi-asserted-by":"crossref","first-page":"3663","DOI":"10.1007\/s00213-015-4026-7","article-title":"Psilocybin-induced spiritual experiences and insightfulness are associated with synchronization of neuronal oscillations","volume":"232","author":"Kometer","year":"2015","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jns.2022.120302_bb0500","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fnhum.2014.00020","article-title":"The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs","volume":"8","author":"Carhart-Harris","year":"2014","journal-title":"Front. Hum. Neurosci."},{"key":"10.1016\/j.jns.2022.120302_bb0505","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1177\/0269881119895520","article-title":"Therapeutic mechanisms of psilocybin: changes in amygdala and prefrontal functional connectivity during emotional processing after psilocybin for treatment-resistant depression","volume":"34","author":"Mertens","year":"2020","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.jns.2022.120302_bb0510","doi-asserted-by":"crossref","DOI":"10.3389\/fnhum.2016.00269","article-title":"Ego-dissolution and psychedelics: validation of the Ego-dissolution inventory (EDI)","volume":"10","author":"Nour","year":"2016","journal-title":"Front. Hum. Neurosci."},{"key":"10.1016\/j.jns.2022.120302_bb0515","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1007\/s00213-006-0457-5","article-title":"Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance","volume":"187","author":"Griffiths","year":"2006","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jns.2022.120302_bb0520","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2307\/1384454","article-title":"The construction and preliminary validation of a measure of reported mystical experience","volume":"14","author":"Hood","year":"1975","journal-title":"J. Sci. Study Relig."},{"key":"10.1016\/j.jns.2022.120302_bb0525","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1177\/0269881108094300","article-title":"Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later","volume":"22","author":"Griffiths","year":"2008","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.jns.2022.120302_bb0530","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1177\/0022167817709585","article-title":"Patients\u2019 accounts of increased \u201cconnectedness\u201d and \u201cacceptance\u201d after psilocybin for treatment-resistant depression","volume":"57","author":"Watts","year":"2017","journal-title":"J. Humanist. Psychol."},{"key":"10.1016\/j.jns.2022.120302_bb0535","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1146\/annurev.ps.41.020190.002221","article-title":"Personality structure: emergence of the five-factor model","volume":"41","author":"Digman","year":"1990","journal-title":"Annu. Rev. Psychol."},{"key":"10.1016\/j.jns.2022.120302_bb0540","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1177\/0269881111420188","article-title":"Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness","volume":"25","author":"MacLean","year":"2011","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.jns.2022.120302_bb0545","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s00213-017-4733-3","article-title":"Long-lasting subjective effects of LSD in normal subjects","volume":"235","author":"Schmid","year":"2017","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jns.2022.120302_bb0550","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S2215-0366(16)30065-7","article-title":"Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study","volume":"3","author":"Carhart-Harris","year":"2016","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.jns.2022.120302_bb0555","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s00213-017-4771-x","article-title":"Psilocybin with psychological support for treatment-resistant depression: six-month follow-up","volume":"235","author":"Carhart-Harris","year":"2017","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jns.2022.120302_bb0560","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1001\/archgenpsychiatry.2010.116","article-title":"Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer","volume":"68","author":"Grob","year":"2011","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jns.2022.120302_bb0565","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1177\/0269881116675513","article-title":"Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial","volume":"30","author":"Griffiths","year":"2016","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.jns.2022.120302_bb0570","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1177\/0269881116675512","article-title":"Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial","volume":"30","author":"Ross","year":"2016","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.jns.2022.120302_bb0575","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1097\/NMD.0000000000000113","article-title":"Safety and efficacy of lysergic acid diethylamide-assisted psychotherapy for anxiety associated with life-threatening diseases","volume":"202","author":"Gasser","year":"2014","journal-title":"J. Nerv. Ment. Dis."},{"key":"10.1016\/j.jns.2022.120302_bb0580","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s00213-020-05719-1","article-title":"Classic serotonergic psychedelics for mood and depressive symptoms: a meta-analysis of mood disorder patients and healthy participants","volume":"238","author":"Galv\u00e3o-Coelho","year":"2021","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jns.2022.120302_bb0585","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s00213-020-05756-w","article-title":"The acute effects of classic psychedelics on memory in humans","volume":"238","author":"Healy","year":"2021","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jns.2022.120302_bb0590","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0063972","article-title":"Psychedelics and mental health: A population study","volume":"8","author":"Krebs","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jns.2022.120302_bb0595","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1177\/0269881114565653","article-title":"Classic psychedelic use is associated with reduced psychological distress and suicidality in the United States adult population","volume":"29","author":"Hendricks","year":"2015","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.jns.2022.120302_bb0600","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1177\/0269881114568039","article-title":"Psychedelics not linked to mental health problems or suicidal behavior: A population study","volume":"29","author":"Johansen","year":"2015","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.jns.2022.120302_bb0605","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3390\/brainsci8030047","article-title":"Hallucinogen persisting perception disorder: etiology, clinical features, and therapeutic perspectives","volume":"8","author":"Martinotti","year":"2018","journal-title":"Brain Sci."},{"key":"10.1016\/j.jns.2022.120302_bb0610","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1111\/ajad.12577","article-title":"Comparing triggers to visual disturbances among individuals with positive vs negative experiences of hallucinogen-persisting perception disorder (HPPD) following LSD use","volume":"26","author":"Lev-Ran","year":"2017","journal-title":"Am. J. Addict."},{"key":"10.1016\/j.jns.2022.120302_bb0615","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/j.euroneuro.2014.05.008","article-title":"Hallucinogen persisting perception disorder and the serotonergic system: A comprehensive review including new MDMA-related clinical cases","volume":"24","author":"Litjens","year":"2014","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.jns.2022.120302_bb0620","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/j.addbeh.2005.02.005","article-title":"Side effects of dextromethorphan abuse, a case series","volume":"30","author":"Ziaee","year":"2005","journal-title":"Addict. Behav."},{"key":"10.1016\/j.jns.2022.120302_bb0625","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.euroneuro.2014.11.002","article-title":"The cannabinoid system and visual processing: A review on experimental findings and clinical presumptions","volume":"25","author":"Schwitzer","year":"2015","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.jns.2022.120302_bb0630","doi-asserted-by":"crossref","first-page":"9791","DOI":"10.1007\/s11033-020-06009-x","article-title":"Psychedelics as an emerging novel intervention in the treatment of substance use disorder: A review","volume":"47","author":"DiVito","year":"2020","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.jns.2022.120302_bb0635","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2021.103380","article-title":"Classic psychedelics in the treatment of substance use disorder: potential synergies with twelve-step programs","volume":"98","author":"Yaden","year":"2021","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.jns.2022.120302_bb0640","series-title":"Psychological and Social Determinants of Drug Action. The Dynamics of Psychiatric Drug Therapy","first-page":"297","author":"Sarwer-Foner","year":"1960"},{"key":"10.1016\/j.jns.2022.120302_bb0645","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1177\/0269881116677852","article-title":"Set and setting, psychedelics and the placebo response: an extra-pharmacological perspective on psychopharmacology","volume":"30","author":"Hartogsohn","year":"2016","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.jns.2022.120302_bb0650","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s00213-017-4820-5","article-title":"The hidden therapist: evidence for a central role of music in psychedelic therapy","volume":"235","author":"Kaelen","year":"2018","journal-title":"Psychopharmacology"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X22001642?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X22001642?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T16:00:15Z","timestamp":1758384015000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X22001642"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":130,"alternative-id":["S0022510X22001642"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2022.120302","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Review of potential psychedelic treatments for PTSD","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2022.120302","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"120302"}}